A quantitative approach to the design of antitumor drug dosage schedule via cell cycle kinetics and systems theory.
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D002455:Cell Division; D002470:Cell Survival / Q000187:drug effects; D003561:Cytarabine / Q000627:therapeutic use; D004273:DNA, Neoplasm / Q000378:metabolism; D004334:Drug Administration Schedule; D007700:Kinetics; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000473:pathology; D008954:Models, Biological; D008956:Models, Chemical; D009369:Neoplasms / Q000188:drug therapy / Q000473:pathology
D000970:Antineoplastic Agents; D004273:DNA, Neoplasm; D003561:Cytarabine